← Leaderboards
Angela K Birnbaum
University Of Minnesota
$4,856,357
Attributed
$6,822,513
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,822,513 · 5
By mechanism
R01$5,443,160 · 3
P50$966,654 · 1
R21$412,699 · 1
Top collaborators
- Page Buckhannan Pennell4 shared
- Silvia Martinez Illamola2 shared
- Monica M Luciana2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Mark R. Schleiss$10,248,102
- Page Buckhannan Pennell$12,920,589
- Michael Tsai$21,953,199
- Nathan Schuldt$3,896,550
- Carol L Cheatham$2,018,240
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponsePharmaceutical PreparationsVisitDoseEpilepsyDrug KineticsProspectiveEnzymesSiteLamotrigineLevetiracetamKidneyToxic EffectSeizuresExposure ToDrug ExposureCytochrome P450ProgramsBloodFoundationsCognitionInnovationMetabolismAntidepressive Agents
Grant awards (16)
Neurobehavioral Impacts of Medical Cannabis Use: An Observational Study$653,970
R01 · FY2025 · DA
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$546,216
R01 · FY2025 · HD · contact PI
Neurobehavioral Impacts of Medical Cannabis Use: An Observational Study$663,150
R01 · FY2024 · DA
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$539,430
R01 · FY2024 · HD · contact PI
Pharmacokinetic/Pharmacodynamic model in pregnant women with depression to guide sertraline dosing$189,233
R21 · FY2023 · HD
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$550,360
R01 · FY2022 · HD · contact PI
Pharmacokinetic/Pharmacodynamic model in pregnant women with depression to guide sertraline dosing$223,466
R21 · FY2022 · HD
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$566,488
R01 · FY2021 · HD · contact PI
Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients$387,714
R01 · FY2011 · AG · contact PI
Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients$418,518
R01 · FY2010 · AG · contact PI
Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients$388,100
R01 · FY2009 · AG · contact PI
Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients$384,449
R01 · FY2008 · AG · contact PI
Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients$344,765
R01 · FY2007 · AG · contact PI
PHARMACOEPIDEMIOLOGY OF THE ANTIEPILEPTIC DRUGS$334,522
P50 · FY2006 · NS · contact PI
PHARMACOEPIDEMIOLOGY OF THE ANTIEPILEPTIC DRUGS$334,522
P50 · FY2005 · NS
PHARMACOEPIDEMIOLOGY OF THE ANTIEPILEPTIC DRUGS$297,610
P50 · FY2002 · NS